Coherus Oncology (CHRS) Net Margin (2013 - 2026)
Coherus Oncology (CHRS) reported Net Margin of 11.31% for Q1 2026, up 10938.0% on a YoY basis from N/an in Q1 2025, and down 116.56% sequentially from 68.28% in Q4 2025.
Coherus Oncology (CHRS) Net Margin (2013 - 2026) Analysis & Trends
Coherus Oncology (CHRS) has 13 years of Net Margin data on file, last reported at 11.31% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 10938.0% year-over-year to 11.31%; the trailing twelve-month figure through Mar 2026 stood at 765.58% (up 56039.0% YoY), and the FY2025 full-year result was 832.66%, down 9160.0% from the prior year.
- Net Margin fell to 11.31% in Q1 2026, from 68.28% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 7405.16% in Q1 2024 to a low of 233.47% in Q1 2023.
- A 5-year average of 629.8% and a median of 59.52% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin soared 763863 bps in 2024 and tumbled 752584 bps in 2025, its largest moves.
- Tracing CHRS's Net Margin over 5 years: stood at 129.81% in 2022, then surged by 33 bps to 87.03% in 2023, then soared by 32 bps to 59.52% in 2024, then surged by 215 bps to 68.28% in 2025, then tumbled by 117 bps to 11.31% in 2026.
- Business Quant data shows CHRS's Net Margin at 11.31% in Q1 2026, 68.28% in Q4 2025, and 77.66% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | -11.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.31% |
| Dec 31, 2025 | 68.28% |
| Sep 30, 2025 | 77.66% |
| Jun 30, 2025 | 3,341.42% |
| Mar 31, 2025 | -120.69% |
| Dec 31, 2024 | -59.52% |
| Sep 30, 2024 | 608.86% |
| Jun 30, 2024 | 407.25% |
| Mar 31, 2024 | 7,405.16% |
| Dec 31, 2023 | -87.03% |
| Sep 30, 2023 | -53.16% |
| Jun 30, 2023 | -73.01% |
| Mar 31, 2023 | -233.47% |
| Dec 31, 2022 | -129.81% |
| Sep 30, 2022 | -190.76% |
| Jun 30, 2022 | -83.37% |
| Mar 31, 2022 | -159.83% |
| Dec 31, 2021 | -62.28% |
| Sep 30, 2021 | -46.70% |
| Jun 30, 2021 | -34.12% |